+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Dup15q Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Dup15q Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
E-Selectin Inhibitor- Pipeline Insight, 2025 - Product Thumbnail Image

E-Selectin Inhibitor- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
NF-kappa B Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

NF-kappa B Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
D Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

D Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 120 Pages
  • Global
From
H Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

H Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 120 Pages
  • Global
From
Matrix Metalloproteinase (MMP) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Matrix Metalloproteinase (MMP) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 120 Pages
  • Global
From
Alpha Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Alpha Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 120 Pages
  • Global
From
5-HT2 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

5-HT2 Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 120 Pages
  • Global
From
5-HT1 Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

5-HT1 Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Dopaminergic Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Dopaminergic Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 120 Pages
  • Global
From
Diabetic Macular Edema (DME) - Pipeline Insight, 2025 - Product Thumbnail Image

Diabetic Macular Edema (DME) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Human Papillomavirus (HPV) Associated Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Human Papillomavirus (HPV) Associated Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Congenital Heart Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Congenital Heart Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Acne Vulgaris- Pipeline Insight, 2025 - Product Thumbnail Image

Acne Vulgaris- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Hypothalamic Obesity (HO) - Pipeline Insight, 2025 - Product Thumbnail Image

Hypothalamic Obesity (HO) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Primary Progressive Aphasia - Pipeline Insight, 2025 - Product Thumbnail Image

Primary Progressive Aphasia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Lambert-Eaton Myasthenic Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Lambert-Eaton Myasthenic Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Pyoderma Gangrenosum (PG) - Pipeline Insight, 2025 - Product Thumbnail Image

Pyoderma Gangrenosum (PG) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Pseudoxanthoma Elasticum - Pipeline Insight, 2025 - Product Thumbnail Image

Pseudoxanthoma Elasticum - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more